✦ LIBER ✦

New Prognostic Score Based on Treatment Outcome of Patients With Relapsed Hodgkin's Lymphoma Registered in the Database of the German Hodgkin's Lymphoma Study Group

✍ Scribed by Josting, A.

Book ID: 124073594
Publisher: American Society of Clinical Oncology
Year: 2002
Tongue: English
Weight: 208 KB
Volume: 20
Category: Article
ISSN: 0732-183X
DOI: 10.1200/JCO.20.1.221

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A population-based study of the outcome

A population-based study of the outcome for patients with first relapse of Hodgkin's lymphoma

✍ Rose-Marie Amini; Bengt Glimelius; Anita Gustavsson; Tor Ekman; Martin Erlanson; 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB

Treatment-Related Mortality in Patients

✍ Wongso, D.; Fuchs, M.; Plutschow, A.; Klimm, B.; Sasse, S.; Hertenstein, B.; Mas 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 178 KB

The Impact of Sarcopenia on Transplant-R

The Impact of Sarcopenia on Transplant-Related Outcomes in Patients with Non-Hodgkin's and Hodgkin's Lymphoma

✍ Caram, Megan Veresh; Bellile, Emily Light; Englesbe, Michael; Terjimanian, Micha 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 88 KB

The German Hodgkin Study Group Stratific

The German Hodgkin Study Group Stratification Scheme for Newly Diagnosed Hodgkin Lymphoma Is Useful for Predicting Outcome of Patients Receiving Radiation Therapy After Autologous Self Cell Transplant in Relapsed/Refractory Hodgkin Lymphoma

✍ Furlan, C.; Michieli, M.; Bortolus, R.; Mascarin, M.; Avanzo, M.; Rupolo, M.; Za 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Phase II study of elsamitrucin (BMY-2809

Phase II study of elsamitrucin (BMY-28090) for the treatment of patients with refractory/relapsed non-Hodgkin's lymphoma

✍ S. L. Allen; L. P. Schacter; S. M. Lichtman; R. Bukowski; D. Fusco; M. Hensley; 📂 Article 📅 1996 🏛 Springer US 🌐 English ⚖ 351 KB

CEOP treatment results and validity of t

CEOP treatment results and validity of the International Prognostic Index in Chinese patients with aggressive non-Hodgkin's lymphoma

✍ C. S. Chim; Y. L. Kwong; A. K. W. Lie; C. K. Lee; R. Liang 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB 👁 2 views

From 1991 to 1997, we have treated 78 newly diagnosed patients with aggressive non-Hodgkin's lymphoma with a modified CHOP regimen in which epirubicin (60 mg/m 2 ) was used in place of doxorubicin (50 mg/m 2 ), i.e. CEOP (cyclophosphamide, epirubicin, vincristine and prednisolone). The median age wa